Publications
183
Citations
9,299
Est. group size
—
Recurring co-author estimate
Active years
45
Publishing since 1981
Paul A. Sobotka's work focuses on hypertension and heart failure, particularly device-based and physiology-guided approaches to treatment. His research covers renal nerve ablation (denervation) for high blood pressure, hemodynamic (blood flow and pressure)-guided drug therapy, and catheter-based interventions such as splanchnic nerve modulation and arteriovenous anastomosis for managing heart failure and blood pressure. This research would suit students interested in clinical trials and interventional approaches to cardiovascular disease.
Publication output has been fairly steady but modest over the last decade, fluctuating between 1 and 5 papers per year without a clear upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- HAEMODYNAMICALLY-GUIDED SELECTION OF THERAPY IMPROVES BLOOD PRESSURE CONTROL EFFICIENTLY IN PRIMARY CARE
Journal of Hypertension · 2025
- Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial
EClinicalMedicine · 2024
- The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined
Heart Failure Reviews · 2024
- Pharmacologic treatment of hypertension guided by non-invasive haemodynamics in primary care improves blood pressure control
European Heart Journal · 2024
- Blood Pressure Variability in Clinical Practice: Past, Present and the Future
Journal of the American Heart Association · 2023
- Congestion and Inflammation in Heart Failure: Beyond the Chicken or the Egg
Journal of Cardiac Failure · 2023
- A physiologic, precision-medicine approach to guided pharmacological treatment of hypertension substantially improves blood pressure in a large community-based cohort
European Heart Journal · 2023
- Endpoints for Clinical Effects of Renal Denervation: What Is the Best Surrogate?
2023
- Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study
Journal of Cardiovascular Translational Research · 2022
- Catheter-Based Management of Heart Failure
Interventional Cardiology Clinics · 2022
- Extracardiac Abnormalities of Preload Reserve
Circulation Heart Failure · 2021
- Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations
European Journal of Heart Failure · 2021
- Renal Denervation for Patients With Heart Failure
Circulation Heart Failure · 2021
- Iliocaval Venous Obstruction, Cardiac Preload Reserve and Exercise Limitation
Journal of Cardiovascular Translational Research · 2020
- Sham trials: benefits and risks for cardiovascular research and patients
The Lancet · 2019
- European Heart Journal×3
- Journal of Cardiovascular Translational Research×3
- Journal of Hypertension×3
- European Journal of Heart Failure×2
- Journal of the American Heart Association×2
- Soolim Jeong
Medicine · Indiana University
- Arjun Sinha
Medicine · Indiana University
- Andrew Tran
Medicine · The Ohio State University
- J W Kim
Medicine · The Ohio State University
- James Brian Byrd
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile